<DOC>
	<DOC>NCT00223015</DOC>
	<brief_summary>Steady state pharmacokinetics of tacrolimus, mycophenolat mofetil and fluvastatin in renal transplant patients are investigated to look for potential interaction between these drugs. All patient enrolled in this PKI-Study had no changes in the therapy before or because of the study. Only patients without changes more than 4 weeks were included</brief_summary>
	<brief_title>Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>renal transplant patients (18 65 years, inclusive) cadaver and living renal transplants(1. Ntx, 2. Ntx) Immunsuppression: Tacrolimus with or without Mycophenolat Mofetil und and fluvastatin Fluvastatin for a minimum of three months writen informt consent by the patient contraindications for statins pregnancy or lactating elevated liver or muscle encymes (&gt; 2x up to normal values: AST, ALT, bilirubine, CPK)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2004</verification_date>
	<keyword>renal transplantation</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Fluvastatin</keyword>
	<keyword>Mycophenolat mofetil</keyword>
	<keyword>tacrolimus</keyword>
</DOC>